AAAAAA

   
Results: 1-15 |
Results: 15
INVESTIGATION OF THE MOLECULAR-CHANGES DURING CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA
Authors: YAZICI H SAIP P INANC S ONAT H DALAY N
Citation: H. Yazici et al., INVESTIGATION OF THE MOLECULAR-CHANGES DURING CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA, Research communications in molecular pathology and pharmacology, 100(3), 1998, pp. 301-311
HIGH-DOSE EPIRUBICIN (EPI) AND CISPLATINUM (C) IN LOCALLY ADVANCED UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA (UNPC)
Authors: ONAT H ESASSOLAK M INANC ES SANACAK Y BASARAN M HAYDAROGLU A ALIUN M
Citation: H. Onat et al., HIGH-DOSE EPIRUBICIN (EPI) AND CISPLATINUM (C) IN LOCALLY ADVANCED UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA (UNPC), European journal of cancer, 34, 1998, pp. 155-155
CISPLATIN AND EPIRUBICIN INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIOTHERAPY IN LIMITED STAGE SMALL-CELL LUNG-CANCER (LS-SCLC)
Authors: CAY F ONAT H SAIP P KARS A DEMIRKAZIK A AKBULUT H KOCA S AKYOL F AKTAN G FIRAT D
Citation: F. Cay et al., CISPLATIN AND EPIRUBICIN INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIOTHERAPY IN LIMITED STAGE SMALL-CELL LUNG-CANCER (LS-SCLC), Annals of oncology, 9, 1998, pp. 502-502
HIGH-DOSE EPIRUBICIN AND CISPLATIN INDUCTION CHEMOTHERAPY SEQUENTIALLY FOLLOWED BY IFOSFAMIDE AND ETOPOSIDE CHEMOTHERAPY IN EXTENSIVE-STAGESMALL-CELL LUNG-CANCER (ES-SCLC)
Authors: DEMIRKAZIK A ONAT H SAIP P OZGUROGLU M KARS A CAY F DEMIR G UNER A ARPACI F AKTAN G
Citation: A. Demirkazik et al., HIGH-DOSE EPIRUBICIN AND CISPLATIN INDUCTION CHEMOTHERAPY SEQUENTIALLY FOLLOWED BY IFOSFAMIDE AND ETOPOSIDE CHEMOTHERAPY IN EXTENSIVE-STAGESMALL-CELL LUNG-CANCER (ES-SCLC), Annals of oncology, 9, 1998, pp. 505-505
HIGH-DOSE IFOSPHAMIDE IN REFRACTORY, RECURRENT AND METASTATIC SARCOMA
Authors: INANC SE ALICI S SAIP P KURUL S ONAT H
Citation: Se. Inanc et al., HIGH-DOSE IFOSPHAMIDE IN REFRACTORY, RECURRENT AND METASTATIC SARCOMA, Annals of oncology, 9, 1998, pp. 567-567
CLINICAL EFFICACY OF DIAZEPAM IN PROPHYLAXIS OF ACUTE AND DELAYED EMESIS INDUCED BY CISPLATIN-BASED CHEMOTHERAPY - A PROSPECTIVE RANDOMIZEDTRIAL
Authors: SAIP P ONAT H BASARAN M TAS F DEMIR C UYGUN K TOPUZ E
Citation: P. Saip et al., CLINICAL EFFICACY OF DIAZEPAM IN PROPHYLAXIS OF ACUTE AND DELAYED EMESIS INDUCED BY CISPLATIN-BASED CHEMOTHERAPY - A PROSPECTIVE RANDOMIZEDTRIAL, Annals of oncology, 9, 1998, pp. 701-701
PREDICTION OF RADIOLOGICAL RESPONSE OF BONE METASTASES TO THERAPY BY BIOCHEMICAL MARKER MONITORING IN PATIENTS WITH BREAST-CANCER - A PRELIMINARY-STUDY
Authors: SAIP P YASASEVER V TENEKECI N AYDINER A INANC S ONAT H DISCI R TOPUZ E
Citation: P. Saip et al., PREDICTION OF RADIOLOGICAL RESPONSE OF BONE METASTASES TO THERAPY BY BIOCHEMICAL MARKER MONITORING IN PATIENTS WITH BREAST-CANCER - A PRELIMINARY-STUDY, Journal of tumor marker oncology, 13(3), 1998, pp. 45-52
PROLONGED SURVIVAL WITH COMPLETE RESECTION OF LUNG METASTASES
Authors: INANC SE ONAT H DARENDELILER E CAMLICA H KALAYCI G
Citation: Se. Inanc et al., PROLONGED SURVIVAL WITH COMPLETE RESECTION OF LUNG METASTASES, European journal of cancer, 33, 1997, pp. 522-522
AUTOIMMUNE PHENOMENA IN PATIENTS RECEIVING ALPHA-INTERFERON THERAPY
Authors: INANC SE ONAT H OGUZ H TOPUZ E
Citation: Se. Inanc et al., AUTOIMMUNE PHENOMENA IN PATIENTS RECEIVING ALPHA-INTERFERON THERAPY, Cancer investigation, 14(6), 1996, pp. 642-643
PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING NEOADJUVANT CHEMOTHERAPY (CISPLATIN, EPIRUBICIN, BLEOMYCIN) PLUS RADIOTHERAPY VS RADIOTHERAPY ALONE IN STAGE-IV (GREATER-THAN-OR-EQUAL-TO-N2, M0) UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA - A POSITIVE EFFECT ON PROGRESSION-FREESURVIVAL
Authors: CVITKOVIC E ESCHWEGE F RAHAL M",DOSEN,"MERSIC Z KRAJINA Z ARMAND JP BOUHRIS J TUBIANAMATHIEU M FOUNTZILAS G KOSMIDIS PA PRASAD U GANESAN S ELGUEDDARI B BACHOUCHI M MANSOURI A OLIVEIRA J RAPOSO J WIERZBICKI R LIANES P PENA C ONAT H ALTUN M BENHAMOU E DUCOURTIEUX M AZLI N FANDI A TAAMMA A BOSQ J KLIJANIENKO J SIGAL R HONG WK VOKES EE CLARK JR LEFLOCH O BERNIER J
Citation: E. Cvitkovic et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING NEOADJUVANT CHEMOTHERAPY (CISPLATIN, EPIRUBICIN, BLEOMYCIN) PLUS RADIOTHERAPY VS RADIOTHERAPY ALONE IN STAGE-IV (GREATER-THAN-OR-EQUAL-TO-N2, M0) UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA - A POSITIVE EFFECT ON PROGRESSION-FREESURVIVAL, International journal of radiation oncology, biology, physics, 35(3), 1996, pp. 463-469
TURKISH HEART-STUDY - LIPIDS, LIPOPROTEINS, AND APOLIPOPROTEINS
Authors: MAHLEY RW PALAOGLU KE ATAK Z DAWSONPEPIN J LANGLOIS AM CHEUNG V ONAT H FULKS P MAHLEY LL VAKAR F OZBAYRAKCI S GOKDEMIR O WINKLER W
Citation: Rw. Mahley et al., TURKISH HEART-STUDY - LIPIDS, LIPOPROTEINS, AND APOLIPOPROTEINS, Journal of lipid research, 36(4), 1995, pp. 839-859
ACUTE COAGULATION CHANGES DURING CYTOTOXIC CHEMOTHERAPY
Authors: ONAT H INANC S KARALOGLU D ERTURK N DALAY N YASASEVER V
Citation: H. Onat et al., ACUTE COAGULATION CHANGES DURING CYTOTOXIC CHEMOTHERAPY, Journal of experimental & clinical cancer research, 13(1), 1994, pp. 89-92
SWEETS-SYNDROME AND HODGKINS-DISEASE
Authors: INANC SE ALTUN M ONAT H ERSEVEN G
Citation: Se. Inanc et al., SWEETS-SYNDROME AND HODGKINS-DISEASE, Acta oncologica, 33(5), 1994, pp. 574-575
BRIEF WEEKLY CHEMOTHERAPY FOR ELDERLY PATIENTS WITH INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA
Authors: INANC SE ONAT H
Citation: Se. Inanc et H. Onat, BRIEF WEEKLY CHEMOTHERAPY FOR ELDERLY PATIENTS WITH INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA, Journal of the National Cancer Institute, 85(13), 1993, pp. 1088-1089
TESTICULAR GERM-CELL TUMOR WITH GASTRIC METASTASIS
Authors: AYDINER A OLGAC V DARENDELILER E OZTURK N DINCOL K ERSEVEN G ONAT H
Citation: A. Aydiner et al., TESTICULAR GERM-CELL TUMOR WITH GASTRIC METASTASIS, Acta oncologica, 32(4), 1993, pp. 459-460
Risultati: 1-15 |